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Conclusion: A considerable number of MPX cases (23.1%) had
“conjunctivitis” as a symptom of their illness. The majority of these
were young children (<10 yrs.) who also had a higher frequency
of other symptoms. These individuals were also more likely to be
“bed-ridden”.MPXcaseswith “conjunctivitis” are at risk for corneal
scarring, which can cause blindness. Understanding the underlying
cause of “conjunctivitis” in monkeypox patients will be important,
as somemaybe amenable to treatment (e.g., Triﬂourodine has been
used to treat Orthopoxvirus-associated corneal lesions). Improv-
ing the availability of ophthalmologic resources in areas endemic
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Background: According to the WHO, malaria remains a major
health problem emphasized by the reduction of P. falciparum
susceptibility to Artemisinin and derivatives and an increasing
resistanceof vectors to insecticideshighlighting theurgentneed for
new antimalarial leads.This work aimed to discover new antiplas-
modial extract from Cameroonian ﬂora.
Methods & Materials: Crude extract of P. suaveolens (leaves,
stem bark, twigs, stem and trunk) obtained by maceration in
ethanol 95% were subsequently partition between CH2Cl2/H20 and
MeOH90%/Hexane to affordmethanolic fractions (acetogenin–rich
fractions). The Flowcytometry–basedassaywasused todetermine
the IC50 of extract against chloroquine resistant strain of P. falcipa-
rum (W2). A phytochemical screeningwas performed to determine
the group of bioative secondarymetabolites. The safety of fractions
with good activity were assayed on healthy Swiss albino mice by
oral administration at up to 5000mg/kg.
Results: Among twenty extracts from P. suaveolens prepared,
six exhibited a very good activity with IC50 <5g/mL ranged
from 3.212 to 4.530g/mL. Four acetogenin–rich fractions of
twigs, stem-bark, stems and trunk showed a very good activity.
The ethanolic extract of twigs showed inhibiton with a IC50 of
5,754g/mL. Promising fractions (methanol fractions) of P. suave-
olens were safe orally with no death or toxicity signs.
Conclusion: This result support the traditional use of P. suave-
olens to treat malaria and relative symptoms. Meanwhile, further
investigations are required toward the development of new
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Background: Previous studies showed that in areas of seasonal
malaria transmission, intermittent preventive treatment of school
children (IPTsc) targeting the transmission season, reduced the
rates of clinical malaria. The efﬁcacy of ACTs in the context of lon-
gitudinal IPTsc is poorly investigated and school performance has
not been thoroughly evaluated.
Methods & Materials: This was an open randomized con-
trolled trial of seasonal IPT among school children aged 6–13
years in Kolle, Mali. The study began in September 2007 and
completed follow-up in June 2013. Students were randomized to
one of three study arms: Sulphadoxine–pyrimethamine plus arte-
sunate (SP/AS), Amodiaquine plus artesunate (AQ/AS) or Control
(C). All students received two full treatment doses, given 2 months
apart during the season of high transmission from September to
December. Groups were compared with respect to school perfor-
mance, incidenceof clinicalmalaria, asymptomaticparasitemiaand
anaemia.
Results: A total of 296 students were randomized, and reten-
tion in the study was 99.3%. Yearly grade average and success
rate in the SP/AS and AQ/AS arms were (5.37; 79.1%) and (4.87;
70.5%) respectively vs. control (4.81; 68.7%) (P<0.05). Clinical
malaria incidence in the SP/AS and AQ/AS arms was reduced by
50.9% and 20.6%, respectively, vs. control (P<0.001). There were
fewer all-cause clinic visits among the children receiving SP/AS or
AQ/AS (P<0.001). Theprevalenceof asymptomaticparasitemiawas
higher in the control group than in the SP/AS or AQ/AS (P<0.001)
groups. At the end of the transmission period, children treatedwith
IPT showed a trend towards lower rates of anaemia (SP/AS, 4.2%;
AQ/AS, 7.8%; Control, 12.7%;P=0.012).
Conclusion: IPTsc with SP/AS reduced the rates of clinical
malaria, all-cause acute clinic visits and asymptomatic parasitemia
and trended towards a reduction in anaemia among school-aged
children while improving markers of school performance.
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